China Approves Sino Biopharm’s First-In-Class Oral Molecule For 1L Myelofibrosis

 
• By Xu Hu
  
China awards global-first approval to new class of drug for myelofibrosis. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from China